SK287337B6 - Použitie zlúčenín, ktoré sú kombinovanými selektívnymi inhibítormi (SSRI) reabsorpcie serotonínu (5-HT) a agonistami receptora 5-HT1A na výrobu liečiva - Google Patents
Použitie zlúčenín, ktoré sú kombinovanými selektívnymi inhibítormi (SSRI) reabsorpcie serotonínu (5-HT) a agonistami receptora 5-HT1A na výrobu liečiva Download PDFInfo
- Publication number
- SK287337B6 SK287337B6 SK638-2003A SK6382003A SK287337B6 SK 287337 B6 SK287337 B6 SK 287337B6 SK 6382003 A SK6382003 A SK 6382003A SK 287337 B6 SK287337 B6 SK 287337B6
- Authority
- SK
- Slovakia
- Prior art keywords
- butyl
- physiologically acceptable
- treatment
- piperazine
- serotonin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00124815 | 2000-11-14 | ||
| PCT/EP2001/011952 WO2002040024A1 (en) | 2000-11-14 | 2001-10-16 | Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK6382003A3 SK6382003A3 (en) | 2003-11-04 |
| SK287337B6 true SK287337B6 (sk) | 2010-07-07 |
Family
ID=8170369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK638-2003A SK287337B6 (sk) | 2000-11-14 | 2001-10-16 | Použitie zlúčenín, ktoré sú kombinovanými selektívnymi inhibítormi (SSRI) reabsorpcie serotonínu (5-HT) a agonistami receptora 5-HT1A na výrobu liečiva |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040082594A1 (cs) |
| EP (1) | EP1333832B1 (cs) |
| JP (1) | JP2004513924A (cs) |
| KR (1) | KR20030059244A (cs) |
| CN (1) | CN1222291C (cs) |
| AR (1) | AR031335A1 (cs) |
| AU (2) | AU2002215027B2 (cs) |
| BR (1) | BR0115296A (cs) |
| CA (1) | CA2428511C (cs) |
| CZ (1) | CZ302484B6 (cs) |
| DE (1) | DE60131675T2 (cs) |
| ES (1) | ES2296820T3 (cs) |
| HU (1) | HUP0302751A3 (cs) |
| MX (1) | MXPA03004166A (cs) |
| NO (1) | NO20032148L (cs) |
| PL (1) | PL204331B1 (cs) |
| RU (1) | RU2288719C2 (cs) |
| SK (1) | SK287337B6 (cs) |
| UA (1) | UA79583C2 (cs) |
| WO (1) | WO2002040024A1 (cs) |
| ZA (1) | ZA200304606B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10305739A1 (de) * | 2003-02-11 | 2004-08-19 | Merck Patent Gmbh | Benzofuranderivate |
| DK1701940T3 (da) | 2003-12-23 | 2008-09-08 | Lundbeck & Co As H | 2-(1H-indolylsulfanyl)-bensylaminderivater som SSRI |
| US7893261B2 (en) | 2004-03-26 | 2011-02-22 | Baylor University | Serotonin reuptake inhibitors |
| AR052308A1 (es) | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| WO2006034788A1 (en) * | 2004-09-28 | 2006-04-06 | Merck Patent Gmbh | Combinations of n-(indolecarbonyl-)piperazine derivatives and serotonin reuptake inhibitors |
| AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| JP2010500386A (ja) * | 2006-08-11 | 2010-01-07 | ディーエスエム アイピー アセッツ ビー．ブイ． | 中枢神経系の障害を治療するためのリグスチリド誘導体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
| DE19512639A1 (de) * | 1995-04-05 | 1996-10-10 | Merck Patent Gmbh | Benzonitrile und -fluoride |
| DE19637237A1 (de) * | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
| DE19730989A1 (de) * | 1997-07-18 | 1999-01-21 | Merck Patent Gmbh | Piperazin-Derivate |
| KR20010070997A (ko) * | 1998-07-20 | 2001-07-28 | 플레믹 크리스티안 | 비페닐 유도체 |
-
2001
- 2001-10-16 WO PCT/EP2001/011952 patent/WO2002040024A1/en active IP Right Grant
- 2001-10-16 KR KR10-2003-7006473A patent/KR20030059244A/ko not_active Ceased
- 2001-10-16 US US10/416,573 patent/US20040082594A1/en not_active Abandoned
- 2001-10-16 JP JP2002542397A patent/JP2004513924A/ja active Pending
- 2001-10-16 PL PL360310A patent/PL204331B1/pl not_active IP Right Cessation
- 2001-10-16 HU HU0302751A patent/HUP0302751A3/hu unknown
- 2001-10-16 AU AU2002215027A patent/AU2002215027B2/en not_active Ceased
- 2001-10-16 ES ES01983555T patent/ES2296820T3/es not_active Expired - Lifetime
- 2001-10-16 CA CA002428511A patent/CA2428511C/en not_active Expired - Fee Related
- 2001-10-16 BR BR0115296-3A patent/BR0115296A/pt not_active Application Discontinuation
- 2001-10-16 SK SK638-2003A patent/SK287337B6/sk not_active IP Right Cessation
- 2001-10-16 CZ CZ20031433A patent/CZ302484B6/cs not_active IP Right Cessation
- 2001-10-16 CN CNB018188591A patent/CN1222291C/zh not_active Expired - Fee Related
- 2001-10-16 EP EP01983555A patent/EP1333832B1/en not_active Expired - Lifetime
- 2001-10-16 AU AU1502702A patent/AU1502702A/xx active Pending
- 2001-10-16 DE DE60131675T patent/DE60131675T2/de not_active Expired - Lifetime
- 2001-10-16 MX MXPA03004166A patent/MXPA03004166A/es active IP Right Grant
- 2001-10-16 UA UA2003065408A patent/UA79583C2/uk unknown
- 2001-10-16 RU RU2003115431/15A patent/RU2288719C2/ru not_active IP Right Cessation
- 2001-11-14 AR ARP010105299A patent/AR031335A1/es unknown
-
2003
- 2003-05-13 NO NO20032148A patent/NO20032148L/no not_active Application Discontinuation
- 2003-06-12 ZA ZA200304606A patent/ZA200304606B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1060697A1 (en) | 2004-08-20 |
| MXPA03004166A (es) | 2003-09-22 |
| HUP0302751A3 (en) | 2007-06-28 |
| DE60131675D1 (de) | 2008-01-10 |
| AU1502702A (en) | 2002-05-27 |
| SK6382003A3 (en) | 2003-11-04 |
| CA2428511A1 (en) | 2002-05-23 |
| KR20030059244A (ko) | 2003-07-07 |
| EP1333832A1 (en) | 2003-08-13 |
| PL360310A1 (en) | 2004-09-06 |
| WO2002040024A1 (en) | 2002-05-23 |
| US20040082594A1 (en) | 2004-04-29 |
| NO20032148D0 (no) | 2003-05-13 |
| UA79583C2 (en) | 2007-07-10 |
| ZA200304606B (en) | 2004-09-13 |
| JP2004513924A (ja) | 2004-05-13 |
| EP1333832B1 (en) | 2007-11-28 |
| DE60131675T2 (de) | 2008-11-20 |
| BR0115296A (pt) | 2003-09-02 |
| CN1474691A (zh) | 2004-02-11 |
| AR031335A1 (es) | 2003-09-17 |
| ES2296820T3 (es) | 2008-05-01 |
| CZ302484B6 (cs) | 2011-06-08 |
| AU2002215027B2 (en) | 2006-10-05 |
| NO20032148L (no) | 2003-05-13 |
| CA2428511C (en) | 2009-12-29 |
| CN1222291C (zh) | 2005-10-12 |
| PL204331B1 (pl) | 2010-01-29 |
| RU2288719C2 (ru) | 2006-12-10 |
| CZ20031433A3 (cs) | 2003-09-17 |
| HUP0302751A2 (hu) | 2003-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Papastefanou et al. | The effect of butorphanol on the incidence of dexmedetomidine-induced emesis in cats | |
| SK287337B6 (sk) | Použitie zlúčenín, ktoré sú kombinovanými selektívnymi inhibítormi (SSRI) reabsorpcie serotonínu (5-HT) a agonistami receptora 5-HT1A na výrobu liečiva | |
| AU2002215027A1 (en) | Novel uses of combined 5-HT1A agonists and serotonin reuptake inhibitors | |
| CZ294904B6 (cs) | Saredutant a jeho farmaceuticky přijatelné soli pro přípravu léčiva, použitelného k léčení nebo prevenci poruch nálady, poruch adaptace nebo stavů úzkosti a deprese | |
| RU2283648C2 (ru) | Новое применение комбинированных селективных антагонистов допаминового рецептора d2 и агонистов рецептора 5-нт 1a | |
| Rahman et al. | Clinical evaluation of different treatment regimes for management of myiasis in cattle | |
| SK14552001A3 (sk) | Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady | |
| KR20230159526A (ko) | 타시피미딘 제형 및 이의 용도 | |
| HK1060697B (en) | Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors | |
| EA001623B1 (ru) | Соединения из класса ацилмочевин, предназначенные для лечения кокцидиоидомикоза у теплокровных животных | |
| WO2015075003A1 (en) | Reducing pain in male animals during castration | |
| US5369128A (en) | Method of synchronizing farrowing in swine | |
| HK1060698A (en) | Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists | |
| KR20230161995A (ko) | 포유동물에서 진드기 감염을 제어하는 사료 및 방법 | |
| Jensen | Evaluation of the occurrence of arthritis in nursing piglets, strategically treated shortly after birth with an injection of amoxicillin or by topical application of chlortetracycline on the navel, and in untreated controls. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20141016 |